Month: July 2012

There is a news story once a week about Suboxone. A pill to treat your addiction to pills? Is that madness? Is it different than methadone? There has been a lot of press about Suboxone, so here are the basic facts about this drug. 1. Suboxone is used in the United States for the treatment… Read More

Diabetes care has gotten better. Two new long acting insulins are taking over NPH insulin. They are more expensive, and many of you ask: which is better, Lantus or Levemir insulin? Here is the story of the new long-acting insulins. For adult onset (Type II) diabetics who have been on maximum doses of diabetes pills… Read More

Update 5/29/2014: On May 14, 2014, the US Public Health Service released the first HIV pre-exposure prophylaxis (PrEP) guidelines, developed by the CDC and other agencies. The guidelines mention the first study referenced below, which showed that Truvada reduced risk overall by 44% in the population studied. However, in even better news, among men with… Read More

This story should get under your skin. GlaxoSmithKline (GSK), the drug company that makes Wellbutrin (bupropion), has agreed to pay $3 billion to the federal government. GSK plead guilty to charges of illegally promoting two antidepressants and withholding key safety information about the diabetes drug Avandia. As part of the settlement, the drug company admitted… Read More

The Food and Drug Administration approved the obesity drug lorcaserin (Belviq) on June 27 despite concerns from physicians and others that it might increase the risk of valve disease. It may be time to get excited about a new weight loss medication, but let’s get to know it. Previous weight loss medications like Meridia and Fen-phen… Read More